CryoCase: Rethink the standard. Replace the bag.

CryoCase: Rethink the standard. Replace the bag.

Discover the groundbreaking CellSeal® CryoCase™, the first rigid primary container engineered for closed-system fluid processing in cell and gene therapy (CGT) applications. Launched in November 2024, the CryoCase offers unmatched fracture resistance, transparency for quality inspections, and automation-ready design, addressing the common pitfalls of traditional cryobags and cryovials. With proven performance in freeze-thaw processes and enhanced contamination control, CryoCase is revolutionizing CGT manufacturing workflows. Explore white papers, webinars, and case studies to see how CryoCase can transform your storage solutions. Learn more or request your test sample today!

How the BioLife Solutions Master File Letter Request Process Works for CryoStor® and HypoThermosol® FRS

Gloved hand checks box on regulatory approval

Cross-Referencing BioLife Master Files CryoStor and HypoThermosol FRS (HTS-FRS) are critical components in many customer cell and gene therapy (CGT) and regenerative medicine processes. Although they are not regulated medical products—meaning they are not classified as drugs, medical devices, or marketed/registered as excipients—they serve a critical role as ancillary/raw materials in cell-based manufacturing processes. BioLife […]

How Does a Water-Free Automated Thawing System Improve Your Cryopreservation Process?

ThawSTAR Water-free Thawing System

Cryopreservation has come a long way… Over the past 50 years, advances in biopreservation techniques have enabled industry-wide progress in a range of fields including cell biology research, drug discovery, biobanking, assisted reproduction, and even plant and animal conservation, with the fields of cellular therapy and regenerative medicine seeing the greatest expansion recently. As these […]

Overcoming Cryopreservation Challenges

Cryopreservation Best Practices

Navigating the Challenges of Cryopreservation in Cell-Based Research Biopreservation, and specifically cryopreservation, is critical for maintaining the viability of cells long-term throughout storage and research. Recently, BioLife Solutions partnered with Cell and Gene Therapy Insights to produce a poster that highlights many of the challenges researchers face, balanced with Biopreservation Best Practice suggestions. To receive […]

Journal Articles Citing CryoStor CS10® Recently Added to BioLife Solutions’ Evidence Library

blue 3D T-Cell Image

Multiple Uses for CryoStor in Cell Manufacturing Journal articles recently added to BioLife Solutions’ Evidence Library illustrate several stages during the cell manufacturing process for which CryoStor CS10® cryopreservation solution is applicable. The three articles that follow include several different cell types cryopreserved in CryoStor CS10. An expanded list of cell types biopreserved in BioLife […]

Cellular Therapies for COVID-19 Highlighted During ISCT Paris 2020 (VIRTUAL)

T-cell graphic

The global impact of COVID-19 on our lives has been profound at virtually every level. Personally, professionally, politically, and economically, the pandemic impacts our lives, our relationships, and how we conduct business. We begin and end the day with the latest news on SARS-CoV-2, and up-to-the-minute COVID-19 data. In between, we must surmount any number […]

This website uses cookies to ensure you get the best experience on our website.